Projected Impact of a Sodium Consumption Reduction Initiative in Argentina: An Analysis from the CVD Policy Model - Argentina

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Konfino, Jonatan ^a,b   Mekonnen, Tekeshe A ^c,d   Coxson, Pamela G ^c,d   Ferrante, Daniel ^b   Bibbins Domingo, Kirsten ^c,d  

^a Centro de Estudios de Estado y Sociedad   (Argentina)

^b National Ministry of Health   (Argentina)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGENTINA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE POLICY; HEART INFARCTION; HUMAN; MALE; MORBIDITY; OUTCOME ASSESSMENT; SEX DIFFERENCE; SODIUM EXCRETION; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ADULT; ARGENTINA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HEALTH PROMOTION; HUMANS; HYPERTENSION; MALE; MODELS, CARDIOVASCULAR; SODIUM, DIETARY; SURVIVAL RATE; TIME FACTORS;

EID: 84883642983     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073824     Document Type: Article

References (38)

1. Mathers C, Loncar D, (2006) Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med 3: e442.
2. Ministerio de Salud de la Nación (2012) Estadisticas Vitales- Informacion Basica Año 2010. In: Direccion de Estadisticas e Informacion de Salud. Available: http://www.deis.gov.ar/publicaciones/archivos/Serie5Nro52.pdf.
3. World Health Organization (2008) 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Geneva.
4. Ministerio de Salud de la Nación (2011) Segunda Encuesta Nacional de Factores de Riesgo. Buenos Aires: Ministerio de Salud de la Nación.
5. Ferrante D, Apro N, Ferreira V, Virgolini M, Aguilar V, et al. (2011) Feasibility of salt reduction in processed foods in Argentina. Rev Panam Salud Publica 29: 69-75.
6. Ministerio de Salud de la Nación (2011) Estrategia Menos Sal Más Vida.
7. Mattes R, Donnelly D, (1991) Relative contributions of dietary sodium sources. J Am Coll Nutr 10: 383-393.
8. Ministerio de Salud de la Nación (2013) Estrategia piloto para reducir el consumo de sal en la Provincia de La Pampa. Buenos Aires.
9. Elliot P, Brown I (2007) Sodium intakes around the world. Geneva: World Health Organization.
10. Hashimoto T, Yagami F, Owada M, Sugawara T, Kawamura M, (2008) Salt preference according to a questionnaire vs. dietary salt intake estimated by a spot urine method in participants at a health check-up center. Intern Med 47: 399-403.
11. Kawamura M, Kusano Y, Takahashi T, Owada M, Sugawara T, (2006) Effectiveness of a spot urine method in evaluating daily salt intake in hypertensive patients taking oral antihypertensive drugs. Hypertens Res 29: 397-402.
12. Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, et al. (2002) A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens 16: 97-103.
13. Stamler J, (1997) The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr 65: 626S-642S.
14. Kawasaki T, Itoh K, Uezono K, Sasaki H, (1993) A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol 20: 7-14.
15. Weinstein M, Coxson P, Williams L, Pass T, Stason W, et al. (1987) Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health 77: 1417-1426.
16. Tosteson A, Weinstein M, Williams L, Goldman L, (1990) Long-term impact of smoking cessation on the incidence of coronary heart disease. Am J Public Health 80: 1481-1486.
17. Bibbins-Domingo K, Chertow G, Coxson P, Moran A, Lightwood J, et al. (2010) Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 362: 590-599.
18. Moran A, Gu D, Zhao D, Coxson P, Wang YC, et al. (2010) Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes 3: 243-252.
19. Moran A, Degennaro V, Ferrante D, Coxson P, Palmas W, et al. (2011) Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: the Coronary Heart Disease Policy Model. nt J Cardiol 150: 332-337.
20. Konfino J, Ferrante D, Mejía R, Coxson P, Moran A, et al. (2012) Impact on Cardiovascular Disease Events of the implementation of Argentina's National Tobacco Control Law. Tobacco Control.
21. Ferrante D, Konfino J, Mejía R, Coxson P, Moran A, et al. (2012) Relación de la costo utilidad de la disminución del consumo de sal y su efecto en la incidencia de enfermedades cardiovasculares en la Argentina. Revista Panamericana de Salud pública 32: 274-280.
22. Naghavi M, Foreman K, O'Brien J, Pourmalek F, Lozano R (2010) Algorithms for enhancing public health utility of national causes-of-death data. Population Health Metrics 8.
23. Framingham Heart Study CD-ROM (2005) Department of Health and Human Services.
24. Wolf P, D'Agostino R, Belanger A, Kannel W, (1991) Probability of stroke: a risk profile from the Framingham Study. Stroke 22: 312-318.
25. He FJ, MacGregor GA (2004) Effect of longer- term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2001(2):CD000165, 3.
26. Coxson PG, Cook NR, Joffres M, Hong Y, Orenstein D, et al. (2013) Mortality Benefits From US Population-wide Reduction in Sodium Consumption: Projections From 3 Modeling Approaches. Hypertension 61: 564-570.
27. Smith Spangler C, Juusola J, Enns E, Owens D, Garber A, (2010) Desalination of the American Diet: Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease. Annals of Internal Medicine 152: 481-487.
28. D'Agostino R, Grundy S, Sullivan LM, Wilson, CHD Risk Prediction Group, (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286: 180-187.
29. O'Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, et al. (2011) Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 306: 2229-2238.
30. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, European Project on Genes in Hypertension (EPOGH) Investigators (2011) Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305: 1777-1785.
31. Moodie R, Stuckler D, Monteiro C, Sheron N, Neal B, et al. (2013) Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet.
32. Instituto Nacional de Estadísticas y Censos (2011). Ministerio de Economía.
33. Caccavo A, Alvarez A, Bello F, Ferrari A, Carrique A, et al. (2007) Incidencia poblacional del infarto con elevación del ST o bloqueo de rama izquierda a lo largo de 11 años en una comunidad de la provincia de Buenos Aires. Rev Argent Cardiol 75: 185-188.
34. Ministerio de Salud de la Nación, (2011) Factibilidad de Implementación de un sistema de vigilancia telefónico para factores de riesgo de enfermedades crónicas no transmisibles. Boletín de Vigilancia 5: 5-21.
35. Blanco P, Gagliardi J, Higa C, Dini A, Guetta J, et al. (2007) Infarto agudo de miocardio. Resultados de la Encuesta SAC 2005 en la República Argentina. Rev Argent Cardiol 75: 163-179.
36. Sposato L, Esnaola M, Zamora R, Zurru M, Fustinoni O, et al. (2008) Quality of Ischemic Stroke Care in Emerging Countries: The Argentinean National Stroke Registry (ReNACer). Stroke: 3036-3041.
37. Lavados P, Sacks C, Prina L, Escobar A, Tossi C, et al. (2005) Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project). Lancet 365: 2206-2215.
38. Schargrodsky H, Hernandez-Hernandez R, Champagne B, Silva H, Vinueza R, et al. (2008) CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 1: 58-65.